News Lilly names Houston as site for $6.5bn API facility Lilly has named Houston as the second of four locations for new manufacturing facilities that are central to a $27bn investment programme in the US.
News FDA ramps up unannounced inspections of foreign facilities Trump orders the FDA to ease the commissioning of domestic manufacturing facilities, as the regulator announces more unannounced foreign inspections.
News EU proposes legislation to bolster medicines supply chain The EU has proposed legislation to safeguard the supply of critical medicines but pharma and patient groups are concerned about the details.
News Lilly unveils $27bn reshoring drive around four new plants Trump threatened tariffs if businesses do not reshore production to the US - and Lilly has now revealed a $27bn spend on new domestic facilities.
R&D Reshoring the UK pharmaceutical supply chain for future resi... Questions of supply chain security and resiliency have been growing in recent years.
Oncology On looking to a future multiomics approach for CDx, with Jan... The pharmaphorum podcast caught up with Jane Li, VP and general manager for companion diagnostics at Thermo Fisher Scientific, following ESMO 2026.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.